Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Free Cash Flow: 2021-2025

Historic Free Cash Flow for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$112.7 million.

  • Core Scientific's Free Cash Flow fell 342.68% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$344.0 million, marking a year-over-year decrease of 1171.40%. This contributed to the annual value of -$52.1 million for FY2024, which is 206.36% down from last year.
  • Per Core Scientific's latest filing, its Free Cash Flow stood at -$112.7 million for Q3 2025, which was down 29.14% from -$87.3 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Free Cash Flow ranged from a high of $225.8 million in Q4 2021 and a low of -$165.1 million during Q2 2021.
  • In the last 3 years, Core Scientific's Free Cash Flow had a median value of -$9.7 million in 2024 and averaged -$30.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first spiked by 141.50% in 2023, then plummeted by 4,419.89% in 2025.
  • Over the past 5 years, Core Scientific's Free Cash Flow (Quarterly) stood at $225.8 million in 2021, then tumbled by 110.73% to -$24.2 million in 2022, then spiked by 141.50% to $10.1 million in 2023, then slumped by 248.67% to -$15.0 million in 2024, then crashed by 342.68% to -$112.7 million in 2025.
  • Its Free Cash Flow stands at -$112.7 million for Q3 2025, versus -$87.3 million for Q2 2025 and -$129.0 million for Q1 2025.